AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

166.100

-3.400-2.01%

Volume:406.92K

Turnover:67.87M

Market Cap:79.55B

PE:-22.23

High:169.360

Open:167.000

Low:165.790

Close:169.500

52wk High:216.748

52wk Low:88.836

Shares:478.91M

Float Shares:478.91M

Volume Ratio:0.50

T/O Rate:0.08%

Dividend:4.08

Dividend Rate:2.46%

EPS(TTM):-7.473

EPS(LYR):-7.473

ROE:-15.83%

ROA:7.26%

PB:3.85

PE(LYR):-22.23

Loading ...

Overview Company News Filings

CSL Bull Positive on Outlook for Immunoglobulin

3 ASX Dividend Stocks Offering Income Growth Potential

Simply Wall St.

3 Australian Dividend Stocks For Reliable Income In Uncertain Markets

Simply Wall St.

CSL Stock And 2 Income Shares For Steadier Dividends

Simply Wall St.

Top ASX Dividend Stocks For July 2026

Simply Wall St.

How Margin Pressures, Impairments and Leadership Shifts At CSL (ASX:CSL) Have Changed Its Investment Story

Simply Wall St.

CSL Group Acquires Iotm Solutions

Australian Dividend Stocks With Income Support Investors May Want To Check

Simply Wall St.

Australian Dividend Stocks With Strong Yields and Staying Power

Simply Wall St.

CSL Stock And 2 Australian Dividend Shares With Income That Looks More Reliable

Simply Wall St.

QBE Stock And 2 Australian Dividend Shares For Passive Income

Simply Wall St.

EU: Seeks Feedback on Commitments from Sanofi over Possible Anti-competitive Conduct Regarding Rival Flu Vaccine for Vulnerable Patients

THOMSON REUTERS

CSL Stock Leads 3 Australian Dividend Shares Worth A Closer Look

Simply Wall St.

Commonwealth Bank Stock And Other Dividend Compounders For Reliable Income

Simply Wall St.

Carlisle Companies (CSL) Is Down 5.6% After Exit From Key Russell Defensive Indices Is The Bull Case Changed?

Simply Wall St.

QBE Stock And 2 Australian Dividend Shares For Income Focused Portfolios

Simply Wall St.

Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?

Simply Wall St.

Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income

Simply Wall St.

Australian Healthcare Stocks at Two-month High, CSL Rises over 3%

Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/CSL.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":166.1,"timestamp":1789101983843,"preClose":169.5,"halted":0,"volume":406917,"delay":0,"changeRate":-0.020058997050147527,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.47075235363609,"marketStatus":"Trading","change":-3.4,"latestTime":"09-11 14:46:28 AEST","open":167,"high":169.36,"low":165.79,"amount":67869996,"amplitude":0.021062,"askPrice":166.1,"askSize":141,"bidPrice":166.08,"bidSize":49,"shortable":3,"etf":0,"ttmEps":-7.47075235363609,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789106400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":169.5,"dividendRate":0.024532,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.502825,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":169.5,"auctionPrice":167,"auctionVolume":15835,"auctionTime":1789084752163,"referenceTime":1789036203090,"auction":1,"marketStatus":"盘前竞价","timestamp":1789084752163}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.472662,"volumeRatio":0.502825,"shares":478911979,"dividePrice":4.078537,"high":169.36,"amplitude":0.021062,"preClose":169.5,"low":165.79,"week52Low":88.836,"pbRate":"3.85","psRate":"3.61","week52High":216.748,"institutionHeld":0,"latestPrice":166.1,"committee":-0.484211,"eps":-7.472661929790499,"divideRate":0.024555,"volume":406917,"delay":0,"ttmEps":-7.472661929790499,"open":167,"prevYearClose":168.21,"prevWeekClose":172.243,"prevMonthClose":169.351,"prevQuarterClose":113.256,"fiveDayClose":172.243,"twentyDayClose":134.734,"sixtyDayClose":114.815,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653478115","title":"CSL Bull Positive on Outlook for Immunoglobulin","url":"https://stock-news.laohu8.com/highlight/detail?id=2653478115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653478115?lang=en_us&edition=fundamental","pubTime":"2026-07-22 07:46","pubTimestamp":1784677560,"startTime":"0","endTime":"0","summary":"2346 GMT - Pharmaceutical company CSL keeps Morgan Stanley as a bull after reviewing the outlook for immunoglobulin and albumin. MS sees EPS falling 3% and 2% in FY 2026 and 2027, respectively, before rebounding to 8% growth annually over FY 2028-2030. MS stays positive on immunoglobulin's outlook. \"Over the medium to longer-term, we continue to see opportunities in primary and secondary immunodeficiency , key drivers of our industry volume growth forecast of 5.5% per annum through to 2030,\" MS says. In China, it expects regulatory changes to moderate volume growth and hurt selling prices. MS pares forecasts for immunoglobulin and albumin revenue growth. \"However, benefits from immunoglobulin yield initiatives  should support margin expansion within CSL Behring, with our forecasts implying a gross margin of 54.5% by FY32,\" MS says.  Dow Jones NewswiresJuly 21, 2026 19:46 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU1244550221.USD","LU1720051108.HKD","LU2089284900.SGD","BK4086","LU0912757837.SGD","LU1791710582.SGD","LU1989772923.USD","LU2111349929.HKD","LU2271345857.HKD","LU0053666078.USD","LU1064131342.USD","LU0528227936.USD","LU1169590202.USD","LU2028103732.USD","LU1791710400.SGD","LU2357305700.SGD","LU0320765646.SGD","BK7511","CSL","LU1732799900.SGD","LU0882574139.USD","LU1074936037.SGD","SG9999004303.SGD","LU0158827948.USD","LU1244550494.USD","LU0390134368.USD","LU2023251221.USD","LU0225283273.USD","LU1548497426.USD","LU1989772840.SGD","LU1668664300.SGD","KBWB","LU0210528500.USD","LU1732800096.USD","LU2089283258.USD","LU0728928796.USD","LU0006306889.USD","LU1988902786.USD","IAI","LU2487616109.SGD","LU1162221912.USD","LU0098860793.USD","LU0557290698.USD","CSL.AU","BK7067","BK4534","LU2264538146.SGD","BK4588","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652234785","title":"3 ASX Dividend Stocks Offering Income Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2652234785","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652234785?lang=en_us&edition=fundamental","pubTime":"2026-07-18 21:22","pubTimestamp":1784380930,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses can appeal when inflation signals, interest rate expectations and global growth data send mixed messages. While bond yields, housing indicators and consumer confidence move in different directions across the US, Europe, Latin America and Asia, many investors still want regular cash flow from companies with stable, growing payouts. This Dividend Powerhouses screener focuses on stocks with a 5%+ yield that is covered and has a track record of growth and stability. The rest...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-offering-income-growth-potential","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-offering-income-growth-potential","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GOLY","BGLD","OUNZ","GLD","GLDM","UGL","JNUG","DBC","YGLD","EVN.AU","USG","DUST","IAUM","JDST","BEGS","DECU","GBUG","GDXD","VIG","UYM","DULL","KGLD","RING","CEF","BAR","DGZ","IAU","PICK","GOAU","AAAU","NST.AU","DZZ","SGOL","XME","BTGD","PHYS","DGP","SGDM","GDXU","PPI","GLTR","FGDL","CSL.AU","GDXJ","SHNY","GDXY","VOTE","GDX","IAUI","GLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652725444","title":"3 Australian Dividend Stocks For Reliable Income In Uncertain Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2652725444","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652725444?lang=en_us&edition=fundamental","pubTime":"2026-07-17 09:36","pubTimestamp":1784252177,"startTime":"0","endTime":"0","summary":"With inflation readings mixed, bond yields shifting across major markets and policy signals from central banks still in flux, the appeal of cash flow you can see and count is front and center again. Reliable dividend income offers a way to stay invested while letting regular payouts contribute to total returns. The Dividend Powerhouses screener focuses on companies with a 5%+ yield that is covered, growing and historically stable. In this article, you will see three stocks from that list and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-stocks-for-reliable-income-in-uncertai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-stocks-for-reliable-income-in-uncertai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AAAU","GLDM","JDST","RING","XAO.AU","DULL","GDXY","USG","EVN.AU","GBUG","GLTR","UGL","XKO.AU","CSL.AU","OUNZ","SPHQ","UYM","BTGD","DBC","DUST","GOLY","GOAU","KGLD","GDXD","QBE.AU","VIG","PICK","GDX","PPI","IAU","GDXJ","BAR","GLL","SGDM","IAUI","FGDL","JNUG","PHYS","DGP","IAUM","CEF","SGOL","GLDY","SHNY","XME","GDXU","DZZ","BEGS","XJO.AU","GLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497376","title":"CSL Stock And 2 Income Shares For Steadier Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497376","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651497376?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:33","pubTimestamp":1784154832,"startTime":"0","endTime":"0","summary":"With inflation readings moving in different directions across regions and interest rate expectations shifting month by month, many investors are looking for ways to let income, not headlines, do more of the work. That is where the Dividend Powerhouses screener comes in, focusing on stocks offering more than a 5% yield that is covered by current earnings, growing over time and historically steady. This article highlights 3 dividend stocks from that group that stand out on those criteria and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-income-shares-for-steadier-dividends","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-income-shares-for-steadier-dividends","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK7511","BK4086","BK7067","PICK","BK7034","BK7508","BK7506","SGXZ23171101.USD","LU1169590202.USD","LU0728928796.USD","CSL","BK7501","LU1169589451.USD","CSL.AU","BK4535","XME","QBE.AU","UYM","BK7104","EVN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651993584","title":"Top ASX Dividend Stocks For July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651993584","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651993584?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:09","pubTimestamp":1784142556,"startTime":"0","endTime":"0","summary":"As Australian shares experience a modest rise, buoyed by strong U.S. bank earnings and easing consumer prices, investors are increasingly optimistic about the Federal Reserve's potential pause on rate hikes. In this climate of cautious optimism and geopolitical tensions, dividend stocks stand out as a reliable choice for those seeking steady income amidst market fluctuations.","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-july-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-july-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBOZ.AU","BK7501","VAS.AU","CSL.AU","ZYAU.AU","42R.SI","MFF.AU","BK7135","VAP.AU","JIN.AU","KSL.AU","IMLC.AU","PPC.AU","OCL.AU","STW.AU","VIG","XJO.AU","BK7078","IOZ.AU","IISV.AU","QFN.AU","BK6505","XKO.AU","BK7067","GEAR.AU","BEAR.AU","SLF.AU","OZR.AU","BK7058","WAT.AU","XAO.AU","CLX.AU","GIVE.AU","QRE.AU","IIGF.AU","EQT.AU","SDF.AU","EIGA.AU","BK7016","BK6000","BK7508","BK7101","DACE.AU","HDV","OZF.AU","BK7145","BK7118","BK7062","E200.AU","FID.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143137","title":"How Margin Pressures, Impairments and Leadership Shifts At CSL (ASX:CSL) Have Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143137","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143137?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:39","pubTimestamp":1784086784,"startTime":"0","endTime":"0","summary":"In recent weeks, CSL has remained under close investor scrutiny as it works through plasma margin pressures, cash conversion challenges, leadership changes and multi‑billion‑dollar impairments linked mainly to the CSL Vifor acquisition. \nThis combination of operational scrutiny and capital management questions is shaping how investors assess the quality and resilience of CSL’s healthcare franchise ahead of upcoming results and any decision on a potential Seqirus demerger.\nWith plasma margin...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-margin-pressures-impairments-and-leadership-shifts-at-cs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-margin-pressures-impairments-and-leadership-shifts-at-cs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","AIPO","LU1169589451.USD","QTOC","VTHR","BK7501","LU0728928796.USD","ARTY","SG9999004303.SGD","CSL.AU","SGXZ23171101.USD","AGIX","BK4086","BK7508","LU1169590202.USD","CHAT","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651727691","title":"CSL Group Acquires Iotm Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2651727691","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651727691?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:43","pubTimestamp":1784025805,"startTime":"0","endTime":"0","summary":"CSL Group acquires IoTM SolutionsECI-backed CSL acquired IoTM Solutions to build a global platform for multi-carrier IoT connectivity management and eSIM orchestration.IoTM’s cloud-native platform man","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3kYP1j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7511","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651121710","title":"Australian Dividend Stocks With Income Support Investors May Want To Check","url":"https://stock-news.laohu8.com/highlight/detail?id=2651121710","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651121710?lang=en_us&edition=fundamental","pubTime":"2026-07-14 09:31","pubTimestamp":1783992684,"startTime":"0","endTime":"0","summary":"With oil prices, bond yields and inflation worries back in focus, many investors are looking for income that feels steadier than the latest headline. That is where the Dividend Powerhouses screener comes in. It zeroes in on stocks with a 5%+ yield that is covered by earnings, growing and historically stable. Instead of chasing short-term market swings, you are focusing on companies that have made regular cash payouts a core part of their story. In this article, you will see three of the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-income-support-investors-may","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-income-support-investors-may","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GBUG","DGP","GXDW","BTGD","IAUM","EVN.AU","VOTE","BAR","PHYS","DUST","PICK","BEGS","AAAU","SHNY","IAU","GDXJ","GOLY","USG","GLTR","JDST","SGOL","NST.AU","DBC","DULL","ISBC","GLL","OUNZ","GOAU","CSL.AU","GDX","DZZ","GDXU","CEF","UGL","GDXY","XKO.AU","GDXD","GLDM","XME","XAO.AU","RING","IAUI","JNUG","SGDM","PPI","DECU","FEBU","XJO.AU","UYM","FGDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651169354","title":"Australian Dividend Stocks With Strong Yields and Staying Power","url":"https://stock-news.laohu8.com/highlight/detail?id=2651169354","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651169354?lang=en_us&edition=fundamental","pubTime":"2026-07-13 04:28","pubTimestamp":1783888093,"startTime":"0","endTime":"0","summary":"With inflation trends mixed across regions and central banks weighing their next moves, many investors are looking for income streams that feel steadier than headline news. The Dividend Powerhouses (3%+ Yield) screener focuses on companies offering dividend yields above 5% that are described as well covered, growing and stable. That combination can appeal if you want your portfolio to lean on cash returns while bond markets and policy expectations keep shifting. In this article, you will see...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-strong-yields-and-staying-po","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-strong-yields-and-staying-po","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DUST","GOAU","GLL","PW","CSL.AU","GDX","DBC","XME","PPI","AAAU","SHNY","QBE.AU","GDXJ","VIG","GBUG","GDXU","SGDM","UYM","BAR","DULL","XAO.AU","EVN.AU","DZZ","GDXD","IAUM","USG","ZYAU.AU","SGOL","RING","BEGS","OUNZ","DGP","BTGD","CEF","JNUG","XKO.AU","PICK","GDXY","GLDM","JDST","OZR.AU","FGDL","IAUI","GEAR.AU","XJO.AU","IAU","UGL","GLTR","PHYS","GOLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650815260","title":"CSL Stock And 2 Australian Dividend Shares With Income That Looks More Reliable","url":"https://stock-news.laohu8.com/highlight/detail?id=2650815260","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650815260?lang=en_us&edition=fundamental","pubTime":"2026-07-12 01:33","pubTimestamp":1783791231,"startTime":"0","endTime":"0","summary":"With inflation trends mixed across regions and bond yields easing in several major markets, many investors are looking for income that feels more reliable than short term sentiment swings. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% dividend yield that is described as well covered, growing and stable, which can appeal if you want cash returns while policy expectations and growth signals keep shifting. In this article, you will see three stocks from...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-with-income-that","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-australian-dividend-shares-with-income-that","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","XKO.AU","SPHQ","VAP.AU","BK7067","STW.AU","VIG","IISV.AU","VGFPF","GXDW","UYM","SG9999004303.SGD","QFN.AU","QBE.AU","OZR.AU","BK7104","LU0728928796.USD","BK7511","BK4086","VOTE","BK4535","DACE.AU","OZF.AU","XME","XJO.AU","BK7506","GIVE.AU","BK4588","BBOZ.AU","LU1169589451.USD","PICK","VAS.AU","EVN.AU","IIGF.AU","QRE.AU","CSL","IMLC.AU","IOZ.AU","SLF.AU","E200.AU","EIGA.AU","BK7034","FEBU","BEAR.AU","GEAR.AU","XAO.AU","ZYAU.AU","DECU","SGXZ23171101.USD","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185389","title":"QBE Stock And 2 Australian Dividend Shares For Passive Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185389","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185389?lang=en_us&edition=fundamental","pubTime":"2026-07-10 13:27","pubTimestamp":1783661267,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses, often grouped with Dividend Aristocrats, can be especially appealing when inflation trends, bond yields and growth expectations are all pulling investors in different directions. With central banks weighing their next moves and energy prices influencing both inflation and income assets, a screen that focuses on dividend yields above 5% that are well covered, growing and stable offers a clear, rules based way to seek income from equities. This article highlights three...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-passive-incom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-passive-incom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","BTGD","DGZ","PICK","SHNY","IAUM","XAO.AU","GDXJ","DULL","BBOZ.AU","GBUG","GDXY","QBE.AU","XME","JDST","DZZ","IAUI","XJO.AU","JNUG","RING","DBC","GLL","GOLY","UGL","BEGS","CEF","GLDM","PPI","EVN.AU","USG","VAS.AU","DGP","PHYS","VIG","AAAU","OUNZ","CSL.AU","BAR","SGOL","SLF.AU","GDX","GOAU","DUST","SGDM","GLTR","IAU","UYM","FGDL","GDXD","GDXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649696268","title":"EU: Seeks Feedback on Commitments from Sanofi over Possible Anti-competitive Conduct Regarding Rival Flu Vaccine for Vulnerable Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649696268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649696268?lang=en_us&edition=fundamental","pubTime":"2026-07-08 17:45","pubTimestamp":1783503900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nS8N41H0FB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","CSL.AU","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649579709","title":"CSL Stock Leads 3 Australian Dividend Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2649579709","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649579709?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:24","pubTimestamp":1783481061,"startTime":"0","endTime":"0","summary":"With inflation signals mixed across regions and interest rate expectations constantly reassessed, many investors are turning to dividend powerhouses for more predictable income. The Dividend Powerhouses (3%+ Yield) screener focuses on companies paying more than a 5% yield that appears well covered, growing and stable, which can be especially appealing when bond markets and central bank policy paths feel hard to read. Instead of trying to time every macro twist, you can focus on cash flows...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-leads-3-australian-dividend-shares-worth-a-closer","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-leads-3-australian-dividend-shares-worth-a-closer","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK4535","QBE.AU","CEF","XJO.AU","BK7506","BK7508","GBUG","BK7067","XAO.AU","BK7501","OZF.AU","SLF.AU","GEAR.AU","SPHQ","ZYAU.AU","XME","OZR.AU","VAP.AU","IOZ.AU","VOTE","BK4588","XKO.AU","IISV.AU","BK4086","IMLC.AU","EIGA.AU","VIG","GOAU","STW.AU","DACE.AU","QRE.AU","IIGF.AU","BBOZ.AU","GIVE.AU","PICK","CSL","UYM","BK7511","BK4585","EVN.AU","CSL.AU","E200.AU","QFN.AU","BEAR.AU","GLTR","VAS.AU","DECU","BEGS","BK7034"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679412","title":"Commonwealth Bank Stock And Other Dividend Compounders For Reliable Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679412","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679412?lang=en_us&edition=fundamental","pubTime":"2026-07-07 03:37","pubTimestamp":1783366654,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses with yields above 5% can be especially appealing when inflation signals are mixed, growth is cooling in places, and central banks are rethinking rate paths. While bond yields and policy guidance move around, a well covered, growing and stable dividend stream offers a clearer source of potential cash flow. This Dividend Powerhouses screener focuses on exactly that: companies that combine higher income with balance sheet discipline. In this article, you will see 3 of the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-other-dividend-compounders-for-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-other-dividend-compounders-for-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QRE.AU","VAP.AU","GBUG","CEF","SLF.AU","XKO.AU","UYM","ZYAU.AU","EVN.AU","EIGA.AU","IISV.AU","BK4585","BK4535","OZF.AU","GOAU","BK7506","VAS.AU","BEGS","QFN.AU","XME","BK7067","IOZ.AU","BK7511","IMLC.AU","BK7135","PICK","XJO.AU","OZR.AU","BK7508","GIVE.AU","BK7104","BK7501","GEAR.AU","CBA.AU","GLTR","VIG","BBOZ.AU","IIGF.AU","SPHQ","BEAR.AU","E200.AU","CSL.AU","STW.AU","DACE.AU","BK4588","XAO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649136643","title":"Carlisle Companies (CSL) Is Down 5.6% After Exit From Key Russell Defensive Indices Is The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649136643","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649136643?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:18","pubTimestamp":1783304334,"startTime":"0","endTime":"0","summary":"On 27 June 2026, Carlisle Companies Incorporated (NYSE: CSL) was removed from the Russell 1000 Defensive, Russell 1000 Value-Defensive, and Russell 1000 Growth-Defensive indices, prompting rebalancing by index-tracking funds.\nThis simultaneous exit from multiple Russell 1000 defensive-style indices matters because it can alter Carlisle’s investor base and share-trading patterns, with implications for liquidity and ownership mix.\nWe’ll now examine how Carlisle’s removal from several Russell...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-is-down-56-after-exit-from-key-russel","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-is-down-56-after-exit-from-key-russel","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7511","CSL","BK4581","SGLC","BK4585","BK4588","BK4086","LU1169590202.USD","CSL.AU","DEUS","SG9999004303.SGD","LU1169589451.USD","IWF","LU0728928796.USD","BK7501","BK7508","SGXZ23171101.USD","OMFL","FLQL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649915618","title":"QBE Stock And 2 Australian Dividend Shares For Income Focused Portfolios","url":"https://stock-news.laohu8.com/highlight/detail?id=2649915618","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649915618?lang=en_us&edition=fundamental","pubTime":"2026-07-05 14:28","pubTimestamp":1783232896,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and growth signals pulling in different directions across regions, many investors are looking for income streams that feel more resilient than short term market moves. That is where Dividend Powerhouses, companies with yields above 5% that the screener flags as covered, growing and relatively stable, come in. These stocks can help turn market noise into a more predictable cash flow focus. In this article, you will see three stocks from the Dividend Powerhouses...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-income-focuse","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/qbe-stock-and-2-australian-dividend-shares-for-income-focuse","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AAAU","IAUI","GDXY","BEGS","UYM","JDST","RING","SHNY","GDX","EVN.AU","VIG","DZZ","OZR.AU","GDXD","USG","XKO.AU","GLDM","DULL","GOLY","OUNZ","PPI","SGOL","DUST","EIGA.AU","GDXJ","BAR","QBE.AU","FGDL","PICK","XAO.AU","XJO.AU","IAU","BTGD","GBUG","GLTR","CSL.AU","SGDM","DECU","CEF","GLL","GOAU","DGP","PHYS","UGL","XME","DBC","VOTE","IAUM","GDXU","JNUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649691995","title":"Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649691995","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649691995?lang=en_us&edition=fundamental","pubTime":"2026-07-04 22:25","pubTimestamp":1783175140,"startTime":"0","endTime":"0","summary":"The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended revoking CSL Vifor’s TAVNEOS marketing authorisation in the EU, after finding manipulated and unreliable pivotal trial data and prompting CSL to halt new patient starts across EMA jurisdictions.\nThis setback not only raises the prospect of an impairment charge for TAVNEOS intellectual property, but also highlights how regulatory scrutiny can directly test CSL’s diversification benefits and risk...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1169590202.USD","CSL.AU","SGXZ23171101.USD","BK7508","BK7501","CSL","SG9999004303.SGD","BK7067","BK7511","BK4086","AIPO","LU0728928796.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648165489","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2648165489","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648165489?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:36","pubTimestamp":1783060582,"startTime":"0","endTime":"0","summary":"In a world where inflation signals, interest rate expectations and growth data keep shifting, many investors are looking for income that feels more reliable than the latest macro headline. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts can help. This screener focuses on companies that have kept dividends both stable and on an upward path, which can be appealing when bond yields, labor data and central bank messages keep moving around. In this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IIGF.AU","US30Y.BOND","OZF.AU","IOZ.AU","STW.AU","AIPO","VAP.AU","QRE.AU","US5Y.BOND","BK7506","BK7501","GIVE.AU","ARTY","GEAR.AU","TLTW","CHAT","XKO.AU","DACE.AU","BBOZ.AU","AGIX","BK7511","XAO.AU","VAS.AU","US10Y.BOND","BEAR.AU","SLF.AU","CBA.AU","OZR.AU","XJO.AU","IMLC.AU","TLT","BK7135","BK7104","E200.AU","IISV.AU","US2Y.BOND","ZYAU.AU","US12M.BOND","EIGA.AU","BK7508","TMF","QFN.AU","CSL.AU","BK7067","US3Y.BOND","NST.AU","US7Y.BOND","US6M.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648665536","title":"Australian Healthcare Stocks at Two-month High, CSL Rises over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648665536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648665536?lang=en_us&edition=fundamental","pubTime":"2026-07-03 13:48","pubTimestamp":1783057739,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks at two-month high, CSL rises over 3%** Australian health stocks.AXHJrise as much as 2.7%, their highest level since April 22** Stocks gain more than 5% so far this week, their best level since early-November, 2022** Extends gains for a seventh consecutive week** \"Healthcare was battered in the last FY, and has been stabilising in the last couple of months, and investors are finally waking up to how cheap they are in a historical context,\" says Mark Gardner, founder and chief executive officer at MPC Markets** Shares of CSLCSL.AXand CochlearCOH.AXgain over 3% each** Sub-index down ~20% YTD, including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL6N4350AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7007","COH.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648021795","title":"Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648021795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648021795?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:46","pubTimestamp":1782981994,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after the European Medicines Agency’s committee recommended revoking the EU marketing authorisation for Tavneos. This has raised fresh questions about the CSL Vifor unit and the stock’s recent recovery.\nSee our latest analysis for CSL.\nThe Tavneos setback arrives after a sharp 27.21% 1 month share price return for CSL. However, this sits against a weaker backdrop, with the stock down 31.52% year to date and the 1 year total shareholder return declining 49.94%,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4086","LU0728928796.USD","SG9999004303.SGD","BK7501","SGXZ23171101.USD","CSL.AU","BK7508","LU1169590202.USD","BK7511","LU1169589451.USD","CSL","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}